Cysteine Proteinase Inhibitors
"Cysteine Proteinase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES.
| Descriptor ID |
D015853
|
| MeSH Number(s) |
D27.505.519.389.745.325
|
| Concept/Terms |
Cysteine Proteinase Inhibitors- Cysteine Proteinase Inhibitors
- Inhibitors, Cysteine Proteinase
- Proteinase Inhibitors, Cysteine
- Cysteine Protease Inhibitors
- Inhibitors, Cysteine Protease
- Protease Inhibitors, Cysteine
- Cysteine Proteinase Antagonists
- Antagonists, Cysteine Proteinase
- Proteinase Antagonists, Cysteine
alpha-Cysteine Protease Inhibitors- alpha-Cysteine Protease Inhibitors
- Inhibitors, alpha-Cysteine Protease
- Protease Inhibitors, alpha-Cysteine
- alpha Cysteine Protease Inhibitors
|
Below are MeSH descriptors whose meaning is more general than "Cysteine Proteinase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cysteine Proteinase Inhibitors".
This graph shows the total number of publications written about "Cysteine Proteinase Inhibitors" by people in this website by year, and whether "Cysteine Proteinase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cysteine Proteinase Inhibitors" by people in Profiles.
-
Identification of potent small molecule inhibitors of SARS-CoV-2 entry. SLAS Discov. 2022 01; 27(1):8-19.
-
Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Trypanosoma cruzi Cruzain. J Med Chem. 2019 10 24; 62(20):9026-9044.
-
The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism. J Biol Chem. 2016 Feb 12; 291(7):3254-67.
-
Enhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus. Arterioscler Thromb Vasc Biol. 2012 Sep; 32(9):2131-40.
-
Tyrosine nitration of PA700 links proteasome activation to endothelial dysfunction in mouse models with cardiovascular risk factors. PLoS One. 2012; 7(1):e29649.
-
High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration. J Lipid Res. 2009 May; 50(5):807-19.
-
Inhibition of TRIP1/S8/hSug1, a component of the human 19S proteasome, enhances mitotic apoptosis induced by spindle poisons. Mol Cancer Ther. 2006 Jan; 5(1):29-38.
-
Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells. Mol Cancer Ther. 2004 Aug; 3(8):985-92.
-
Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases. J Immunol. 2000 Mar 15; 164(6):2915-23.
-
A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid, blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells. Blood. 1998 Mar 01; 91(5):1625-32.